
    
      A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to
      Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293
      Including an Open-Label Food Effect Group in Healthy Male and Non-Fertile Female Volunteers
    
  